Trials / Terminated
TerminatedNCT05066776
Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
Liquid Biopsy in Combination With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 31 (actual)
- Sponsor
- Palo Alto Veterans Institute for Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if a liquid biopsy, a method of detecting cancer from a blood draw, combined with a PET/CT scan, a type of radiological scan, is better at determining whether a lung nodule is cancerous when compared to a PET/CT scan alone. A PET/CT scan is already used for diagnosis of lung nodules, but its efficacy is uncertain in nodules 6-20 mm in size. Therefore, the PET/CT will be evaluated for its diagnostic ability in lesions this size alone and in combination with a liquid biopsy. Secondarily, a machine learning model will be created to see if the combination of the PET/CT imaging data and the liquid biopsy data can predict the presence of cancer.
Conditions
Timeline
- Start date
- 2021-09-23
- Primary completion
- 2023-02-01
- Completion
- 2023-02-01
- First posted
- 2021-10-04
- Last updated
- 2023-12-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05066776. Inclusion in this directory is not an endorsement.